Emily Mullin / wired - In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.
Back to Top / Thursday, August 7, 2025, 10:21 am / permalink 11840 / 1 stories in 6 months
Gilead to acquire Arcellx for $7.8 billion in cash deal / 11 days
StubHub IPO faces share-price dip on public debut / 5 months
Oracle earnings surge boosts stock and Ellison’s net worth / 5 months
Activist Elliott Takes $4B Stake in PepsiCo / 6 months
Netskope Files for Nasdaq IPO Despite Ongoing Losses / 6 months
Airbnb Beats Q2 Estimates with Robust Earnings Growth / 7 months
Firefly Aerospace IPO Update: Revised Targets and Valuations Emerge / 7 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.